Papa Antonella A

Show results for

Proteomics (2)
Unknown (1)

Organisms

Chaetomium globosum (2)
Phaffia rhodozyma (2)
Naja naja (2)
Naja oxiana (2)
Francisella tularensis subsp. holarctica FSC200 (2)
Streptococcus mutans UA159 (2)
Pteria penguin (2)
Plasmodium falciparum Dd2 (2)
NEWT:502780 (2)
Human alphaherpesvirus 1 (2)
Paulownia fortunei (2)
Metamycoplasma hominis ATCC 23114 (2)
Opsanus beta (2)
Toxoplasma gondii GAB3-2007-GAL-DOM9 (2)
Hypophthalmichthys molitrix (2)
Myotis pilosus (2)
Xylanibacter ruminicola (2)
Bivalvia (2)
bacterium BzS1 (2)
NEWT:479249 (2)
Agrobacterium fabrum str. C58 (2)
Chara australis (2)
environmental samples (2)
Eutrema salsugineum (2)
Beauveria bassiana ARSEF 2860 (2)
Physalis angulata (2)
Clavibacter michiganensis subsp. michiganensis NCPPB 382 (2)
Human respiratory syncytial virus A (2)
Plasmodium (2)
Rapana venosa (2)

Repository

pride (2)

Tissue

Primary cell (1)
Early embryonic cell (1)
Fibroblast (1)
Cell culture (1)
Epithelial cell (1)

Disease

Breast cancer (1)
Disease free (1)

Technology Type

Mass Spectrometry (2)
Shotgun proteomics (2)
SWATH MS (1)

Publication Date

2023 (1)
2020 (1)

Release Date

2025 (1)

Lab affiliation

Cancer Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria 3800, Australia. (1)
Cancer Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, 3800, Australia (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Phosphoproteomics of BYL719 (alpelisib)-Resistant T47D Human Breast Cancer Cell Line

The PI3Kalpha-specific inhibitor Alpelisib (BYL719) has been approved for the treatment of metastatic ER+/HER2- breast cancer patients in combination with Fulvestrant. After initial response, patients develop drug resistance and disease relapses. In order to identify signalling pathways contributing...

ORGANISM(S): Homo sapiens (Human)

2023-12-05 | PXD033956 | Pride

Phosphoproteomics of MEFs with loss-of-function PTEN mutations

The PTEN tumor suppressor controls cell death and survival by regulating functions of various molecular targets. Whilst the role of PTEN lipid-phosphatase activity on PtdIns(3,4,5)P3 and inhibition of PI3K pathway is well characterized, the biological relevance of PTEN protein-phosphatase activity r...

ORGANISM(S): Mus musculus (Mouse)

2020-10-15 | PXD016184 | Pride

Mefs Pten

Status of Sepsis Care in European Hospitals: Results from an International Cross-Sectional Survey.

Not available

S-EPMC12005017 | biostudies-literature

Previous page
1 / 1
You're on page 1
Next page